Cellply Email Format

Biotechnology ResearchEmilia-Romagna, Italy11-50 Employees

Cellply is a Bologna, Emilia-Romagna-based biotechnology company focused on developing analytical tools to deeply characterize cancer immunotherapies, cell therapies, and other cell-based biotherapeutics. Its platform aims to accelerate R&D, improve quality control, and monitor clinical responses by defining immune function at the single-cell level through integration of diverse data. The company, a small to mid-sized operation, relies on proprietary microfluidic-based analysis and AI-driven analytics to yield single-cell insights.
Its customer base comprises researchers and developers working on cell therapies and cancer immunotherapies who need robust potency characterization and immunophenotyping capabilities. In January 2024, Cellply announced the launch of VivaCyte, its flagship end-to-end single-cell potency characterization platform.

Get verified Cellply emails free

Company overview Employee directory